The Swiss Surfer Behind $2 Billion Payments Startup Checkout.com

Indonesia Berita Berita

The Swiss Surfer Behind $2 Billion Payments Startup Checkout.com
Indonesia Berita Terbaru,Indonesia Berita utama
  • 📰 WSJ
  • ⏱ Reading Time:
  • 18 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 10%
  • Publisher: 63%

Guillaume Pousaz, chief of a transaction-processing startup with a soaring valuation, says the future of banking will be built on payments companies

The newest face of the payments frenzy that has investors cheering and bank bosses scrambling is a 37-year-old Swiss surfer who dropped out of college to ride waves up and down the California coast.

Guillaume Pousaz spent roughly a decade transforming a low-tech payments firm he acquired into Checkout.com, a London-based transaction processor for fast-growing internet companies. Fresh off a nine-figure fundraising, the company is beefing up its presence in the U.S. and getting into other financial services, such as issuing...

Berita ini telah kami rangkum agar Anda dapat membacanya dengan cepat. Jika Anda tertarik dengan beritanya, Anda dapat membaca teks lengkapnya di sini. Baca lebih lajut:

WSJ /  🏆 98. in US

Indonesia Berita Terbaru, Indonesia Berita utama

Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.

Monsanto faces thousands of Roundup-cancer lawsuits after $2 billion verdictMonsanto faces thousands of Roundup-cancer lawsuits after $2 billion verdict“We’re not suing them for the fact that their product causes cancer. We’re suing them because they didn’t tell people that it causes cancer.”
Baca lebih lajut »

TransferWise is now Europe's most valuable fintech start-up, with a $3.5 billion valuationTransferWise is now Europe's most valuable fintech start-up, with a $3.5 billion valuationTransferWise, the money transfer start-up, was valued at $3.5 billion after investors bought $292 million of shares in a secondary sale.
Baca lebih lajut »

Nascar to buy International Speedway in deal valued at $2 billion, at a 7% premium to original per-share bidNascar to buy International Speedway in deal valued at $2 billion, at a 7% premium to original per-share bidInternational Speedway Corp. announced Wednesday a deal to be acquired by Nascar Holdings Inc. in a deal valued at $2.0 billion. Under terms of the deal,...
Baca lebih lajut »

Geoffrey Rush awarded $2 million in Sydney defamation caseGeoffrey Rush awarded $2 million in Sydney defamation caseOscar-winning actor Geoffrey Rush awarded $2 million in defamation case over reports he had been accused of inappropriate behavior toward an actress.
Baca lebih lajut »

RNC paid $2 million to law firm employing former White House counsel Donald McGahnRNC paid $2 million to law firm employing former White House counsel Donald McGahnThe RNC said the payment encompassed two years of work by the law firm Jones Day on a variety of matters.
Baca lebih lajut »

This $2 app changed the way I workThis $2 app changed the way I work.NBCNewsBETTER: With the Pomodoro Technique, you pick a task, set a timer for 25 minutes to work on that one thing, take a 5-minute break when the timer rings and repeat.
Baca lebih lajut »

Gene therapy gets FDA approval -- and a $2 million price tagGene therapy gets FDA approval -- and a $2 million price tagThe FDA approved a treatment for a genetic disease called spinal muscular atrophy that causes infants' muscles to waste away, potentially killing them before age 2. The price tag? $2.125 million for a one-time treatment.
Baca lebih lajut »

U.S. approves $2 million Novartis gene therapy for rare, deadly muscle disorderU.S. approves $2 million Novartis gene therapy for rare, deadly muscle disorderZURICH/NEW YORK - Swiss drugmaker Novartis won U.S. approval for its gene therap...
Baca lebih lajut »

Novartis $2 million gene therapy for rare disorder is world's most expensive drugNovartis $2 million gene therapy for rare disorder is world's most expensive drugSwiss drugmaker Novartis won U.S. approval for its gene therapy Zolgensma for spinal muscular atrophy (SMA) and priced the one-time treatment at a record $2.125 million
Baca lebih lajut »



Render Time: 2025-03-13 04:00:45